8/2/19 17:45 | 8/1/19 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | S.d | -6,028 | 44.00 | 0 | -137 | -24 | 441 | D | | | | | | | | | | | | | | |
6/1/18 17:43 | 5/30/18 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,C.E.O. | S.d | -3,420 | 38.00 | 0 | -90 | -21 | 332 | D | | | | | | | | | | | | | | |
2/25/14 18:13 | 2/25/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -3,603 | 37.83 | 33 | -95 | -66 | 48 | D | 63 | 52 | 35 | 35 | 61 | 39 | 24 | 11 | -1 | -2 | -9 | -12 | -3 | -10 |
2/10/14 18:08 | 2/10/14 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -2,806 | 32.07 | 33 | -88 | -64 | 48 | D | 34 | 24 | 7 | 27 | 33 | 29 | 17 | 19 | -3 | -2 | 8 | 12 | 18 | 3 |
5/17/13 17:21 | 5/16/13 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -2,659 | 33.23 | 33 | -80 | -62 | 48 | D | 37 | 28 | 10 | 37 | 35 | 21 | 17 | 0 | 0 | -2 | -19 | -16 | -19 | 12 |
11/21/12 12:44 | 11/20/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.dm | -1,074 | 30.41 | 25 | -35 | -42 | 48 | D | 44 | 53 | 18 | 15 | 9 | 16 | 3 | 0 | -1 | -2 | -10 | -18 | 6 | -7 |
11/13/12 17:12 | 11/12/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -1,860 | 29.91 | 20 | -62 | -56 | 48 | D | 43 | 47 | 16 | 18 | 11 | 16 | 12 | 0 | -1 | 1 | -9 | -19 | 11 | -11 |
11/8/12 16:08 | 11/6/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -776 | 28.75 | 19 | -27 | -36 | 48 | D | 45 | 46 | 16 | 20 | 14 | 11 | 15 | 11 | 0 | 2 | -7 | -11 | 12 | -11 |
9/12/12 16:54 | 9/10/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -535 | 27.00 | 22 | -20 | -29 | 49 | D | 63 | 45 | 8 | 15 | 8 | 5 | 7 | 1 | 0 | 2 | 0 | 2 | -4 | -3 |
5/4/12 16:30 | 5/2/12 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | P,MGL | S.d | -115 | 27.00 | 19 | -4 | -8 | 49 | D | 43 | 18 | 30 | 12 | 15 | 12 | 5 | 2 | 0 | -1 | -12 | -6 | 3 | 8 |
4/7/09 16:05 | 4/6/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,550 | 43.07 | 33 | -36 | -64 | 20 | D | 143 | 113 | 41 | 21 | 6 | 5 | -4 | -4 | 4 | 4 | -25 | -36 | -32 | -41 |
2/11/09 16:47 | 2/9/09 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,870 | 85.40 | 33 | -22 | -88 | 3 | | | | | | | | | | 1 | -1 | -4 | -24 | -32 | -45 |
9/3/08 17:07 | 8/29/08 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -1,223 | 67.93 | 33 | -18 | -75 | 6 | D | 171 | 55 | 85 | 42 | 10 | 1 | 8 | 2 | -3 | -4 | -1 | -14 | 20 | 1 |
8/9/07 16:20 | 8/7/07 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Capone Mark Christopher | UT | O | COO,MGL | S.d | -205 | 43.01 | 33 | -5 | -44 | 6 | D | 155 | 78 | 20 | 17 | 20 | 14 | 19 | 18 | -7 | -9 | 3 | 19 | -12 | 45 |